Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene Varfolomeev

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Medicinal Chemistry|October 30, 2025
Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory DiseasesSnahel Patel, Huifen Chen, Eugene Varfolomeev, et al.
Cell Death and Differentiation|May 19, 2019
RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastasesSnahel Patel, Joshua D Webster, Eugene Varfolomeev, et al.
Cell Reports. Medicine|January 27, 2024
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancerMatthew D Galsky, Xiangnan Guan, Deepali Rishipathak, et al.
Science Signaling|April 20, 2017
The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammationKate Senger, Victoria C Pham, Eugene Varfolomeev, et al.
Journal of Medicinal Chemistry|March 15, 2012
Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)John A Flygare, Maureen Beresini, Nageshwar Budha, et al.
Science Signaling|June 4, 2020
The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cellsCesar A Corzo, Eugene Varfolomeev, A Francesca Setiadi, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Medicinal Chemistry|October 30, 2025
Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory DiseasesSnahel Patel, Huifen Chen, Eugene Varfolomeev, et al.
Cell Death and Differentiation|May 19, 2019
RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastasesSnahel Patel, Joshua D Webster, Eugene Varfolomeev, et al.
Cell Reports. Medicine|January 27, 2024
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancerMatthew D Galsky, Xiangnan Guan, Deepali Rishipathak, et al.
Science Signaling|April 20, 2017
The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammationKate Senger, Victoria C Pham, Eugene Varfolomeev, et al.
Journal of Medicinal Chemistry|March 15, 2012
Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)John A Flygare, Maureen Beresini, Nageshwar Budha, et al.
Science Signaling|June 4, 2020
The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cellsCesar A Corzo, Eugene Varfolomeev, A Francesca Setiadi, et al.
Pageof 4